Thomas Ryder Booth - 12 Feb 2026 Form 4 Insider Report for CHEVRON CORP (CVX)

Role
Chief Technology & Eng Ofr
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for Thomas Ryder Booth
Issuer symbol
CVX
Transactions as of
12 Feb 2026
Net transactions value
-$1,077,067
Form type
4
Filing time
17 Feb 2026, 18:11:49 UTC
Previous filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Booth Thomas Ryder Chief Technology & Eng Ofr 1400 SMITH STREET, HOUSTON /s/ Rose Z. Pierson, Attorney-in-Fact for Thomas Ryder Booth 17 Feb 2026 0002071610

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise $1,169,922 +10,600 +663% $110.37 12,198 12 Feb 2026 Direct
transaction CVX Common Stock Sale $1,954,534 -10,600 -87% $184.39 1,598 12 Feb 2026 Direct
transaction CVX Common Stock Sale $87,841 -476 -30% $184.54 1,122 12 Feb 2026 Direct
transaction CVX Common Stock Sale $204,614 -1,122 -100% $182.37 0 13 Feb 2026 Direct F1
holding CVX Common Stock 3,175 12 Feb 2026 By 401(k) plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10,600 -100% $0.000000 0 12 Feb 2026 Common Stock 10,600 $110.37 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $182.36 to $182.38. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
F2 Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively.